Related Experiment Videos
Psychomotor development of children with congenital hypothyroidism diagnosed by neonatal screening
Insights
Early diagnosis and treatment of congenital hypothyroidism via neonatal screening leads to normal psychomotor development. This contrasts with earlier clinical diagnoses, highlighting the critical role of timely thyroxine therapy for improved child development outcomes.
Area of Science:
- Pediatrics
- Endocrinology
- Developmental Neuroscience
Background:
- Congenital hypothyroidism (CH) can impair psychomotor development if not treated early.
- Previous studies in Sweden showed developmental deficits in clinically diagnosed CH patients.
- Neonatal screening programs aim for early CH detection and intervention.
Purpose of the Study:
- To assess the psychomotor development of infants diagnosed with CH through a nationwide neonatal screening program.
- To compare developmental outcomes in screened CH patients with historical clinical cohorts.
- To determine the impact of early thyroxine replacement therapy on neurodevelopment.
Main Methods:
- A cohort of 68 children with CH diagnosed within the first two years via Swedish neonatal screening was studied.
- Thyroxine replacement therapy initiated at a mean age of 15 days.
- Psychomotor development assessed using Griffiths tests at 18 months and 30-47 months.
Main Results:
- Children with CH diagnosed via screening and treated early showed normal psychomotor development.
- Developmental quotients in the screened CH group did not differ from control children.
- Early treatment significantly improved outcomes compared to previously reported clinically diagnosed CH patients.
Conclusions:
- Neonatal screening for CH enables early detection and timely treatment.
- Early initiation of thyroxine therapy is crucial for achieving normal psychomotor development in CH patients.
- The age at which treatment begins is a key factor influencing the long-term prognosis of congenital hypothyroidism.
Abstract:
The psychomotor development in 68 children with congenital hypothyroidism diagnosed during the first two years of a nationwide neonatal screening programme in Sweden was assessed during their first three years of life. Replacement therapy with thyroxine was initiated at the age of 15 +/- 7 days (mean +/- SD). Griffiths tests were performed in 15 patients at the age of 18 months and in 51 patients at 30-47 months. Their developmental quotients did not differ from those of control children, indicating that the psychomotor development in the children with congenital hypothyroidism was normal. In earlier studies of Swedish children with congenital hypothyroidism, diagnosed clinically before the age of three and a half years, the psychomotor development was found to be impaired. In contrast, the patients diagnosed by neonatal screening and given early therapy displayed normal results in Griffiths tests. This indicates that the age at the start of treatment is an important determinant for the prognosis.